Our Technology
AmritaGen Proprietary Method for delivery crossing the Blood Brain barrier
Composition and method necessary for targeted delivery of agents to cells or tissues, for example central nervous system (CNS) resident cells. The compositions and methods are useful for delivering agents across the blood-brain barrier. The present invention also provides methods of using the compositions provided by the present invention to deliver agents, for example therapeutic agents for the treatment of CNS disorders.
METHOD FOR DELIVERY CROSSING THE BLOOD BRAIN BARRIER
- Capexosome Innovation
-
AmritaGen’s Cap-Exosomes Mediated Drug Delivery to the brain.
-
- Systemic delivery of Cap-exosomes loaded with specific genes and/or FDA-approved drug molecules will have the potential, unlike other sAD therapies currently under developments to rebuild brain circuits and stimulate neuro-glia-vascular synchronized activity that is impaired in patients with mild cognitive impairments (MCI) and sAD patients.
- Rapid Diagnosis Test Development (In Progress)
- Anti-Sense Gene Therapy for Alzheimer’s Disease (In Progress)
-
